Stunting in children aged 12 to 18 months Nutritional, Metabolic, Endocrine
Conditions
Interventions
Participants receive a milk-based oral nutritional supplement (ONS) with an energy density of 1 kcal/ml, a protein-energy ratio (PER) of 13% and 0% sucrose. The product is administered as two servings
a dietary assessment is performed at baseline and Month 5, and growth biomarkers are measured in a sub-sample of participants.
Sponsors
Nestlé (Indonesia)
Eligibility
Sex/Gender
All
Age
12 Months to 18 Months
Inclusion criteria
Inclusion criteria: 1. Children aged 12 to 18 months at the time of enrollment 2. Stunted children, defined as height-for-age Z-score (HAZ) between <2 and =-3 SD according to WHO growth standards 3. Parent(s)/legal guardian(s) willing to provide written informed consent and to allow participation for up to 6 months 4. Willingness to comply with study product administration as prescribed by a pediatrician 5. Ability and willingness to comply with all study procedures and protocol requirements 6. Managed as outpatients and under regular monitoring by pediatrician
Exclusion criteria
Exclusion criteria: 1. Children with short stature not classified as stunting (=-2 SD) 2. Presence of chronic or major medical conditions that may affect growth or feeding, including but not limited to: tuberculosis, prematurity, small for gestational age (SGA), congenital heart disease, or other significant acute/chronic illnesses 3. Requirement for hospitalisation at the time of screening or during enrolment 4. History of cow’s milk protein allergy (CMPA) or lactose intolerance
Countries
Indonesia
Contacts
Public ContactRheinhard Rheinhard
Outcome results
None listed